Work Here?
About Osmind
Industries
Biotechnology
Healthcare
Company Size
51-200
Company Stage
Series B
Total Funding
$57M
Headquarters
San Francisco, California
Founded
2020
Overview
Osmind provides an electronic medical record (EMR) system specifically designed for mental health professionals, including psychiatrists and therapists. The platform features tools for billing, scheduling, patient engagement, and intake forms, all aimed at simplifying the management of mental health practices. It automates the tracking of patient progress and outcomes through measurement-based tools, making it user-friendly even for those less familiar with technology. Unlike many competitors, Osmind operates on a subscription model, allowing practitioners to pay a recurring fee for access, while also offering a flat rate for patient credit card payments without extra transaction fees. The company's goal is to enhance mental health care by improving access to effective treatments and providing excellent customer support to help clients transition smoothly to their EMR system.
Simplify's Take
What believers are saying
- Partnership with Cybin accelerates commercial preparation for innovative psychiatry programs.
- Collaboration with the APA advances quality psychiatric care and research.
- Osmind's virtual visits meet rising telehealth demand, enhancing patient access.
What critics are saying
- Increased competition from new entrants like Valant and SimplePractice.
- Potential data privacy concerns with third-party telehealth platforms like Zoom.
- Challenges in maintaining HIPAA compliance with expanded virtual visit capabilities.
What makes Osmind unique
- Osmind offers a user-friendly EMR platform tailored for mental health professionals.
- The platform integrates measurement-based tools for tracking patient progress and outcomes.
- Osmind's dual revenue model includes subscription fees and patient payment facilitation.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$57M
Meets
Industry Average
Funded Over
3 Rounds
Tiger Global
General Catalyst
Y CombinatorIndustry standards
Benefits
Professional Development Budget
Growth & Insights and Company News
6 month growth
↓ -6%1 year growth
↓ -1%2 year growth
↓ -1%Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, today announced a strategic partnership with Osmind, a leading service provider advancing psychiatry through technology, services, and real-world evidence to bring innovative mental health treatments to patients in need.
SAN FRANCISCO--(BUSINESS WIRE)--Today, Osmind, the leading psychiatric treatment and research platform, announced an innovative collaboration with the American Psychiatric Association (APA) to improve the adoption of measurement-based care (MBC) and precision treatment in psychiatry. This collaboration between Osmind and APA’s PsychPRO registry intends to broaden access to personalized care, improve patient outcomes, generate robust real-world evidence (RWE) and accelerate psychiatry’s evolution to precision medicine. PsychPRO registry is a clinical data registry that enables the collection and analysis of clinical data to advance quality improvement efforts and accelerate research for the psychiatric community. "At Osmind, we emphasize the importance of clinicians participating in evidence-generating medicine to help shape the future of mental health care, especially as the psychiatric field begins to embrace new treatments and precision psychiatry,” said Carlene MacMillan, MD, Chief Medical Officer of Osmind. “Clinicians in private practice juggle many competing demands so it is crucial we make participation both easy and worthwhile to them.". Osmind is integrating a number of APA’s diagnostic and outcomes measures of interest, including the DSM-5-TR Self-Rated Level 1 Cross-Cutting Symptom Measure developed by APA researchers, into its electronic health record (EHR) software
Osmind announces collaboration with the American Psychiatric Association to advance quality psychiatric care and accelerate research.
Starting today, mental health clinicians, practice owners, and researchers have free access to sessions led by the nation's foremost mental health clinicians driving breakthrough medicineSAN FRANCISCO, Dec. 5, 2023 /PRNewswire-PRWeb/ -- Osmind, the public benefit corporation helping clinicians and researchers advance life-saving mental health treatment, today announced its inaugural Breakthrough Mental Health Treatment Forum is now open to virtual attendees. Sessions will focus on mental health treatment research, how to build a successful practice, and the value of community in delivering care. The forum brings together psychiatrists, nurse practitioners, psychotherapists, scientists, clinicians, mental health practice leaders and administrators, and academics all dedicated to advancing therapeutic options for people facing severe and treatment-resistant mental illness."The mental health crisis continues to grow, yet critical advancements in psychiatric treatment are lagging behind," said Lucia Huang, co-founder and CEO of Osmind. "This forum is a unique space for those on the leading edge of novel therapeutic care to hear from leaders driving future innovations on the frontlines of breakthrough mental health care, helping more patients access effective care, and supporting future collaborations."The three-day forum will run from Tuesday, December 5 through Thursday, December 7. Content is available asynchronously
Osmind, the public benefit corporation helping clinicians and researchers advance life-saving mental health treatment, today announced Osmind Claims, which introduces new billing capabilities purpose-built to simplify insurance reimbursement for psychiatric treatment, enabling greater access to insurance-supported mental health care.
Osmind is Hiring for 2 Jobs on Simplify!
Find jobs on Simplify and start your career today
People Also Viewed
Discover companies similar to Osmind
About Osmind
Industries
Biotechnology
Healthcare
Company Size
51-200
Company Stage
Series B
Total Funding
$57M
Headquarters
San Francisco, California
Founded
2020
Osmind is Hiring for 2 Jobs on Simplify!
Find jobs on Simplify and start your career today
People Also Viewed
Discover companies similar to Osmind